5 article(s) from Wang, Yi
Graphical Abstract
Scheme 1: Origin of the reaction design.
Scheme 2: Substrate scope of disulfides.
Scheme 3: Substrate scope of unactivated alkenes.
Scheme 4: Control experiments.
Scheme 5: Proposed mechanism.
Graphical Abstract
Figure 1: Decarboxylative aldol reactions of β-keto acids with aldehydes.
Figure 2: Nucleophilic reaction of α-keto esters to generate tertiary alcohols.
Figure 3: Decarboxylative aldol reactions of β-keto acids with α-keto esters.
Scheme 1: Asymmetric decarboxylative aldol reaction of various β-keto acids with α-keto esters under optimise...
Scheme 2: Proposed mechanism of decarboxylative aldol reaction.
Graphical Abstract
Figure 1: The CF2 group in 1c accelerates RCM reactions relative to CHF (1d) and CH2 (1e) and with a similar ...
Figure 2: X-ray structures of a) 1,1,4,4- (3) b) 1,1,7,7- (4) and c) 1,1,6,6- (5) tetrafluorocyclododecanes. ...
Figure 3: Synthesis targets: Palmitic acid analogues 6a–c.
Scheme 1: Synthesis route to 8,8-difluorohexadecanoic acid (6a).
Scheme 2: The synthesis of palmitic acid analogues 6b and 6c.
Figure 4: DSC traces for the three palmitic acid analogues 6a–c.
Figure 5: The X-ray crystal structures of 8,8-difluorohexadecanoic acid (6a).
Figure 6: The X-ray structure of 8,8,11,11-tetrafluorohexadecanoic acid (6c).
Scheme 3: Synthesis route to the tetrafluorinated alkane 27.
Figure 7: The X-ray structure of 8,8,11,11-tetrafluorononadecane (27).
Figure 8: Conformational interconversion of 1,4-di-CF2 motif.
Graphical Abstract
Figure 1: Catalysts and seleno reagents evaluated in this study.
Figure 2: Generality for substitution at the indoline moiety. The reaction was performed in 0.1 mmol scale in...
Figure 3: X-ray crystallography of 4a catalyzed by (S)-3b.
Scheme 1: The plausible reaction mechanism.
Scheme 2: Scale up of the protocol and synthetic application.
Graphical Abstract
Figure 1: The Dunitz and Shearer structure of cyclododecane (1) [1,2]. There are four endo hydrogens above and fou...
Figure 2: Crystal structures of (a) 1,1,4,4- (b) 1,1,7,7- and (c) 1,1,6,6-tetrafluorocyclododecanes (2–4) , i...
Figure 3: Erythro- and threo-1,2-difluorocyclododecanes (5a and 5b).
Scheme 1: Synthetic routes to erythro- (5a) and threo-1,2-difluorocyclododecane (5b).
Figure 4: X-ray crystal structure of threo-1,2-difluorocyclododecane (5b) showing corner angles and represent...
Figure 5: Variable-temperature 19F{1H} NMR of erythro- (5a) and threo-1,2-difluorocyclododecane (5b).
Figure 6: Calculated relative energies of the conformations of the erythro (5a) and threo (5b) stereoisomers ...